Graphene-VP40 interactions and potential disruption of the Ebola virus matrix filaments.

Jeevan B Gc, Rudramani Pokhrel, Nisha Bhattarai, Kristen A Johnson, Bernard S Gerstman, Robert V Stahelin, Prem P Chapagain
Author Information
  1. Jeevan B Gc: Department of Physics, Florida International University, Miami, FL 33199, United States.
  2. Rudramani Pokhrel: Department of Physics, Florida International University, Miami, FL 33199, United States.
  3. Nisha Bhattarai: Department of Physics, Florida International University, Miami, FL 33199, United States.
  4. Kristen A Johnson: Department of Chemistry and Biochemistry, The Eck Institute for Global Health, The Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, Notre Dame, IN 46556, United States.
  5. Bernard S Gerstman: Department of Physics, Florida International University, Miami, FL 33199, United States; Biomolecular Sciences Institute, Florida International University, Miami, FL 33199, United States.
  6. Robert V Stahelin: Department of Chemistry and Biochemistry, The Eck Institute for Global Health, The Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, Notre Dame, IN 46556, United States; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine-South Bend, South Bend, IN 46617, United States.
  7. Prem P Chapagain: Department of Physics, Florida International University, Miami, FL 33199, United States; Biomolecular Sciences Institute, Florida International University, Miami, FL 33199, United States. Electronic address: chapagap@fiu.edu.

Abstract

Ebola virus infections cause hemorrhagic fever that often results in very high fatality rates. In addition to exploring vaccines, development of drugs is also essential for treating the disease and preventing the spread of the infection. The Ebola virus matrix protein VP40 exists in various conformational and oligomeric forms and is a potential pharmacological target for disrupting the virus life-cycle. Here we explored graphene-VP40 interactions using molecular dynamics simulations and graphene pelleting assays. We found that graphene sheets associate strongly with VP40 at various interfaces. We also found that the graphene is able to disrupt the C-terminal domain (CTD-CTD) interface of VP40 hexamers. This VP40 hexamer-hexamer interface is crucial in forming the Ebola viral matrix and disruption of this interface may provide a method to use graphene or similar nanoparticle based solutions as a disinfectant that can significantly reduce the spread of the disease and prevent an Ebola epidemic.

Keywords

References

  1. Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4275-80 [PMID: 22371572]
  2. Trends Biochem Sci. 2005 Sep;30(9):484-9 [PMID: 16054818]
  3. J Mol Graph Model. 2015 Sep;61:175-85 [PMID: 26275931]
  4. Nat Rev Microbiol. 2009 May;7(5):393-400 [PMID: 19369954]
  5. Future Virol. 2015 May;10(5):537-546 [PMID: 26120351]
  6. Infect Dis Poverty. 2017 May 10;6(1):71 [PMID: 28486978]
  7. N Engl J Med. 2014 Dec 18;371(25):2350-1 [PMID: 25470568]
  8. J Comput Chem. 2004 Oct;25(13):1584-604 [PMID: 15264253]
  9. J Chem Inf Model. 2016 Apr 25;56(4):706-20 [PMID: 26966807]
  10. J Chem Phys. 2016 Jun 14;144(22):225102 [PMID: 27306022]
  11. Nat Nanotechnol. 2013 Aug;8(8):594-601 [PMID: 23832191]
  12. ACS Nano. 2015 Jun 23;9(6):5713-24 [PMID: 26040772]
  13. Lancet. 2011 Mar 5;377(9768):849-62 [PMID: 21084112]
  14. ACS Nano. 2015 Jan 27;9(1):663-9 [PMID: 25494677]
  15. Stat Med. 1995 Oct 30;14(20):2227-37 [PMID: 8552899]
  16. J Comput Chem. 2005 Dec;26(16):1781-802 [PMID: 16222654]
  17. J Phys Chem B. 2015 Oct 8;119(40):12750-9 [PMID: 26374226]
  18. Science. 2009 Apr 10;324(5924):203-7 [PMID: 19359577]
  19. Sci Rep. 2016 Apr 21;6:24906 [PMID: 27097898]
  20. J Virol. 2001 Jun;75(11):5205-14 [PMID: 11333902]
  21. Sci Rep. 2017 Apr 20;7(1):919 [PMID: 28428619]
  22. ACS Nano. 2010 Jan 26;4(1):229-34 [PMID: 20025267]
  23. J Mol Graph. 1996 Feb;14(1):33-8, 27-8 [PMID: 8744570]
  24. Chem Soc Rev. 2015 Oct 7;44(19):6916-53 [PMID: 26139348]
  25. Expert Opin Ther Targets. 2014 Feb;18(2):115-20 [PMID: 24283270]
  26. Virology. 2001 Apr 25;283(1):1-6 [PMID: 11312656]
  27. ACS Appl Mater Interfaces. 2015 Feb 25;7(7):4406-14 [PMID: 25648559]
  28. Nanoscale. 2015 Nov 28;7(44):18725-37 [PMID: 26503908]
  29. Biomaterials. 2014 Jul;35(23):6069-77 [PMID: 24780168]
  30. Cell. 2013 Aug 15;154(4):763-74 [PMID: 23953110]
  31. Nano Lett. 2016 Feb 10;16(2):1027-33 [PMID: 26806020]
  32. PLoS One. 2012;7(1):e29608 [PMID: 22247782]
  33. Sci Rep. 2015 Jun 02;5:10873 [PMID: 26034971]
  34. Nat Med. 2016 Dec;22(12 ):1439-1447 [PMID: 27798615]
  35. J Am Chem Soc. 2016 Feb 24;138(7):2064-77 [PMID: 26824139]
  36. Adv Drug Deliv Rev. 2016 Oct 1;105(Pt B):145-162 [PMID: 27569910]
  37. Arch Virol. 2010 Dec;155(12):2083-103 [PMID: 21046175]
  38. Nature. 2001 Nov 8;414(6860):188-90 [PMID: 11700553]

Grants

  1. R01 AI081077/NIAID NIH HHS

MeSH Term

Binding Sites
Graphite
Molecular Dynamics Simulation
Nucleoproteins
Protein Binding
Protein Conformation
Protein Multimerization
Viral Core Proteins
Viral Matrix Proteins

Chemicals

Nucleoproteins
VP40 protein, virus
Viral Core Proteins
Viral Matrix Proteins
nucleoprotein VP40, Ebola virus
Graphite

Word Cloud

Created with Highcharts 10.0.0EbolavirusVP40graphenematrixinterfacealsodiseasespreadvariouspotentialinteractionsfounddisruptionfilamentsinfectionscausehemorrhagicfeveroftenresultshighfatalityratesadditionexploringvaccinesdevelopmentdrugsessentialtreatingpreventinginfectionproteinexistsconformationaloligomericformspharmacologicaltargetdisruptinglife-cycleexploredgraphene-VP40usingmoleculardynamicssimulationspelletingassayssheetsassociatestronglyinterfacesabledisruptC-terminaldomainCTD-CTDhexamershexamer-hexamercrucialformingviralmayprovidemethodusesimilarnanoparticlebasedsolutionsdisinfectantcansignificantlyreducepreventepidemicGraphene-VP40GraphenesheetMatrixNanotherapy

Similar Articles

Cited By